<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32666099</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Reply: CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort.</ArticleTitle><Pagination><StartPage>e68</StartPage><MedlinePgn>e68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awaa184</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oyston</LastName><ForeName>Lisa J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterton</LastName><ForeName>Zac</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallupp</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajan</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>John B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson-Stone</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 AG052427</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG049507</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UF1 AG047133</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG033193</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG049508</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG052410</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG052409</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG049505</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG052411</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG032984</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG049506</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT097163MA</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>100935/Z/13/Z</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Agency>Department of Health [UK]</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C409984">CYLD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D000074749">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Brain. 2020 Mar 1;143(3):783-799</RefSource><PMID Version="1">32185393</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Brain. 2020 Aug 1;143(8):e67</RefSource><PMID Version="1">32666117</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074749" MajorTopicYN="N">Deubiquitinating Enzyme CYLD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020774" MajorTopicYN="Y">Pick Disease of the Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32666099</ArticleId><ArticleId IdType="pmc">PMC7447510</ArticleId><ArticleId IdType="doi">10.1093/brain/awaa184</ArticleId><ArticleId IdType="pii">5871555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al.Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25: 160&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10835629</ArticleId></ArticleIdList></Reference><Reference><Citation>Degterev A, Zhou W, Maki JL, Yuan J.. Assays for necroptosis and activity of RIP kinases. Methods Enzymol 2014; 545: 1&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">25065884</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C, Hallupp M, Shahheydari H, Ragagnin AMG, Chatterton Z, Carew-Jones F, et al.CYLD is a causative gene for frontotemporal dementia &#x2013; amyotrophic lateral sclerosis. Brain 2020; 143: 783&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="pubmed">32185393</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C, Luty AA, Thompson EM, Blumbergs P, Brooks WS, Short CL, et al.Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis. Acta Neuropathol 2013; 125: 523&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3611035</ArticleId><ArticleId IdType="pubmed">23338750</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo MH, Plummer L, Chan YM, Hirschhorn JN, Lippincott MF.. Burden testing of rare variants identified through exome sequencing via publicly available control data. Am J Hum Genet 2018; 103: 522&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174288</ArticleId><ArticleId IdType="pubmed">30269813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al.Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135: 1311&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2621059</ArticleId><ArticleId IdType="pubmed">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffucci P, Bigio B, Rapaport F, Cobat A, Borghesi A, Lopez M, et al.Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysis. Proc Natl Acad Sci USA 2019; 116: 950&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338851</ArticleId><ArticleId IdType="pubmed">30591557</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell MA, Perez-Jimenez E, Oberst A, Ng A, Massoumi R, Xavier R, et al.Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011; 13: 1437&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3229661</ArticleId><ArticleId IdType="pubmed">22037414</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen BS, Quinlan AR.. Who&#x2019;s who? Detecting and resolving sample anomalies in human DNA sequencing studies with peddy. Am J Hum Genet 2017; 100: 406&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339084</ArticleId><ArticleId IdType="pubmed">28190455</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan N, Ashworth A.. Inherited cylindromas: lessons from a rare tumour. Lancet Oncol 2015; 16: e460&#x2013;e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26370355</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xe1;buas-Pereira M, Santana I, Kun-Rodrigues C, Bras J, Guerreiro R.. CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort. Brain 2020; 143: e67.</Citation><ArticleIdList><ArticleId IdType="pubmed">32666117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>